Authors


Radha Krishnan

Latest:

Managing Biospecimens in Cell and Gene Therapy Trials

Pursuing new tools and capabilities in sample logistics, storage, and data analysis.


Jim Routt

Latest:

Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025

At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.


Zachary Smith

Latest:

Benchmarking the Investigative Site Qualification Process

Insights identify opportunities to optimize sponsor, CRO, and site collaborations.


Jill Sommerville

Latest:

Unleashing Their Potential: The Evolving Landscape of DHTs

Key considerations in deploying fit-for-purpose digital health technologies in drug development.


Mary New

Latest:

Harnessing Patient-Centered Science to Improve Health Outcomes and Commercial Pharma Success

Good scientific principles and practices are essential for maintaining quality data that patients can benefit from.


Lee Andrews II

Latest:

Scaling eSource-Enabled Clinical Trials: Hospital Perspectives

The challenges, opportunities, and strategic outlook for oncology research centers.


Bill Meisle

Latest:

Build Relationships with HCPs to Reach Potential Clinical Trial Patients

Increased outreach is necessary to combat poor recruitment and large focus on patients near study centers.



Samantha S. Williams-Gray

Latest:

Clinical Trials and Trust

Understanding the role of social determinants on clinical trial participation and trust.


Preet Singh

Latest:

Future of Clinical Trial Documentation Management: eTMF Integrated with Blockchain

eTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.


Guy Rachmuth, PhD

Latest:

Integration of Point-of-Care Devices in Clinical Trials

A look at the future of clinical trial laboratory testing amid the emerging use of new devices at the point of care.


Phil Mounteney

Latest:

COVID-19 Five Years Later: The Impact on Drug Discovery

COVID-19 not only advanced scientific boundaries, but also transformed research methodologies and accelerated adaptive clinical trial design.


Jasmina Jankicevic, MD

Latest:

Navigating the New World of Dermatology Trials

How partnering with a CRO that has experience in both dermatology and innovative trial approaches can help sponsors differentiate their studies and facilitate recruitment.


Jiangyuan Luo

Latest:

Towards Data-Driven Clinical Trial Planning and Strategy

Optimizing feasibility through increased data collection.



Marina Acosta Enslen

Latest:

How One CRO Uses RBQM in DCT Implementation

Industry provides endless methods in crafting solutions for patients.


Cerba Research

Latest:

The Importance of NGS Panel Customization

Explore the pivotal role of Next-Generation Sequencing (NGS) panel customization in driving advancements in oncology research.


Liat Edry Botzer, PhD

Latest:

Rethinking ECOG Scores to Improve Patient Access and Clinical Trials Eligibility

Recent study results highlight need for new metrics in ECOG scoring to mitigate variability.


Mark Scullion

Latest:

The Strategic Emergence of Site Networks in Clinical Research

A data-fueled framework for sponsors and CROs in navigating this shifting terrain.


Tai Xie, PhD

Latest:

The Transformation of Clinical Trials from Writing on Papyrus to the World of Technology

New requirements must be put in place to ensure data quality and integrity.


Mike Martin, Jonathan Rowe, Craig Lipset, and Judith Reece

Latest:

Trial Site Engagement Models are Poised for Disruption

The role of the clinical research associate may be key in addressing challenges around the adoption of digital tools.


Dr. Chirag Shah

Latest:

Managing Clinical Trials During the COVID Pandemic

How one CRO in India quickly implemented processes and technology to mitigate risk


Greg Killian

Latest:

New Technology Springs Innovation in Clinical Trials Space

Many companies have implemented new technologies and are adopting clinical trial models that are more patient-centric.


Q2 Solutions (IQVIA)

Latest:

A Global Network to Empower Leaner Oncology Clinical Trials: Unlocking the Potential of Local Genomic Biomarker Testing in Europe

Monday, October 25, 2021 at 10am EDT Attend this webinar to hear about CGP, the latest in onco-innovation for genomic biomarker testing and uncover the role that Illumina and Q2 Solutions are playing in evolving the CGP testing landscape to deliver a localized testing model to support oncology precision medicine clinical trials in Europe. Lastly, the webinar will reveal the updated roadmap of Q2 Solutions’ Edinburgh Genomics laboratory.


Sachin Bharadia

Latest:

ePRO and Ensuring Data Integrity

Push for accurate data collection during pandemic led by increased focus on patient engagement.



Emma DiBella

Latest:

The Value of Integrated Data Views for Clinical Trials

To have a successful integration of data from across clinical systems, a strong understanding of the data is a critical.


Julie Bullock

Latest:

With Project Optimus, Success Favors the Prepared

Oncology drug developers must start asking questions in preparation of FDA’s dose optimization initiative.


Neal Pope

Latest:

Distribution Network Ensures In-Home Trials and Patients Succeed

Industry must work closely with patients to advance the use of decentralized technology.


Gaurav Bhatnagar

Latest:

The 50-Year Technology Drought in Clinical Trials: How AI Teammates Will Finally Bring Us Into the Modern Era

Why a fundamental reimagining of how clinical studies operate is still necessary to achieve a true paradigm shift—and shed the cycle of reliance on incremental gains.

© 2025 MJH Life Sciences

All rights reserved.